Stock Research for IMLFF

IMLFF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

IMLFF Stock Chart & Research Data

The IMLFF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMLFF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


IMLFF Due diligence Resources & Stock Charts

The IMLFF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View IMLFF Detailed Price Forecast - CNN Money CNN View IMLFF Detailed Summary - Google Finance
Yahoo View IMLFF Detailed Summary - Yahoo! Finance Zacks View IMLFF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View IMLFF Trends & Analysis - Trade-Ideas Barrons View IMLFF Major Holders - Barrons
NASDAQ View IMLFF Call Transcripts - NASDAQ Seeking View IMLFF Breaking News & Analysis - Seeking Alpha
Spotlight View IMLFF Annual Report - CompanySpotlight.com OTC Report View IMLFF OTC Short Report - OTCShortReport.com
TradeKing View IMLFF Fundamentals - TradeKing Charts View IMLFF SEC Filings - Bar Chart
WSJ View Historical Prices for IMLFF - The WSJ Morningstar View Performance/Total Return for IMLFF - Morningstar
MarketWatch View the Analyst Estimates for IMLFF - MarketWatch CNBC View the Earnings History for IMLFF - CNBC
StockMarketWatch View the IMLFF Earnings - StockMarketWatch MacroAxis View IMLFF Buy or Sell Recommendations - MacroAxis
Bullish View the IMLFF Bullish Patterns - American Bulls Short Pains View IMLFF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View IMLFF Stock Mentions - StockTwits PennyStocks View IMLFF Stock Mentions - PennyStockTweets
Twitter View IMLFF Stock Mentions - Twitter Invest Hub View IMLFF Investment Forum News - Investor Hub
Yahoo View IMLFF Stock Mentions - Yahoo! Message Board Seeking Alpha View IMLFF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for IMLFF - SECform4.com Insider Cow View Insider Transactions for IMLFF - Insider Cow
CNBC View IMLFF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for IMLFF - OTC Markets
Yahoo View Insider Transactions for IMLFF - Yahoo! Finance NASDAQ View Institutional Holdings for IMLFF - NASDAQ


Stock Charts

FinViz View IMLFF Stock Insight & Charts - FinViz.com StockCharts View IMLFF Investment Charts - StockCharts.com
BarChart View IMLFF Stock Overview & Charts - BarChart Trading View View IMLFF User Generated Charts - Trading View




Latest Financial News for IMLFF


InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
Posted on Friday January 11, 2019

OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that Dr. Sazzad Hossain, PhD, MSc, will assume a position as member of the Scientific Advisory Board ("SAB") and, contemporaneously, announced his retirement as Chief Scientific Officer ("CSO").  Dr. Eric C. Hsu, PhD, Vice President, Pre-Clinical Research & Development, will continue to lead the scientific R&D programs of the Company.


InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
Posted on Thursday January 03, 2019

VANCOUVER , Jan. 3, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (IN.TO) (IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the Biotech Showcase 2019 on Wednesday, January 9, 2019 , at 9:00 AM PT / 12:00 PM ET at the Hilton San Francisco Union Square, in San Francisco, California . A live audio webcast of the presentation will be available through InMed's corporate website in the 'Investor' section at https://investors.inmedpharma.com. InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.


InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
Posted on Tuesday December 04, 2018

OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, is pleased to announce that it has signed a contribution agreement with the National Research Council Canada Industrial Research Assistance Program ("NRC IRAP") to receive funding of up to C$500,000 to support InMed's ongoing R&D efforts in cannabinoid biosynthesis. NRC IRAP provides advisory services and funding to Canadian businesses to promote accelerated growth and technology innovation.


InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
Posted on Monday November 12, 2018

TSX:IN OTCQX:IMLFF VANCOUVER , Nov. 12, 2018 /PRNewswire/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.